AGP Executive Report
Last update: 3 hours agoDrug Safety: Health Canada recalled four lots of PegLyte bowel-prep powder over possible foreign matter. Check lot numbers and consult a health-care provider before stopping it. Weight Care: Canada approved Eli Lilly’s daily Foundayo pill for adults with obesity, or overweight and a related health condition; it is also approved for Type 2 diabetes. Post-Surgery Monitoring: McMaster researchers developed a wearable patch that tracks signs of hidden heart injury after surgery. It could help detect problems once higher-risk patients are home, but remains a research technology. Inuit Children’s Health: A new Inuit-led program is set to receive $575 million over five years, but it will not continue community-wide food vouchers that reached 15,000 children. Cancer Treatment: Saskatchewan will add two drugs to its formulary for eligible ovarian cancer patients whose disease no longer responds to standard treatments, easing out-of-pocket costs. Flu Season: Flu cases have nearly doubled in three weeks, renewing calls for vaccination.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.